Research and Markets: Global Hepatitis C Drugs Market 2011-2015 Features Players GlaxoSmithKline plc, Roche Holding …

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/lxq9wv/global_hepatitis_c) has announced the addition of the "Global Hepatitis C Drugs Market 2011-2015" report to their offering.

TechNavio's analysts forecast the Global Hepatitis C Drugs market to grow at a CAGR of 28 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing prevalence of hepatitis C infection. The Global Hepatitis C Drugs market has also been witnessing the shift of treatments from multiple drug therapy to single drug therapy. However, the virus developing resistance to the drugs could pose a challenge to the growth of this market.

Key vendors dominating this market space include GlaxoSmithKline plc, Merck & Co. Inc., Roche Holding Ltd., and Vertex Pharmaceuticals Ltd.

Commenting on the report, an analyst from TechNavio's Healthcare team said; Vendors are partnering with each other to share their competencies in order to develop more efficient drugs and penetrate the hitherto unexplored market. Hence, vendors are forming strategic alliances with each other to market their manufactured drugs in the unexplored regions and to thereby increase their market share in the Global Hepatitis C Drugs market.

According to the report, novel and newly-introduced drugs such as telaprevir and boceprevir, which are more effective than drugs for multiple drug therapy in the treatment of the hepatitis C infection, have helped to increase the growth of the Global Hepatitis C Drugs market. In addition, several new drugs which are being developed for use in single drug therapy are expected to be launched in the market by 2014. Moreover, these drugs are expected to provide cost-effective treatment for the hepatitis C infection, thereby increasing the growth of the market.

Further, the report also discusses that the unavailability of drugs to meet the market demand adversely affects the growth of the Global Hepatitis C Drugs market.

For more information visit http://www.researchandmarkets.com/research/lxq9wv/global_hepatitis_c

Originally posted here:
Research and Markets: Global Hepatitis C Drugs Market 2011-2015 Features Players GlaxoSmithKline plc, Roche Holding ...